Among patients with rheumatoid arthritis, JAK inhibitors were slightly more effective for reducing pain at 3 and 12 months when compared with TNF inhibitors.

The Simponi biosimilar, AVT05, has shown positive top-line results in patients with moderate to severe rheumatoid arthritis.

The Simponi biosimilar, AVT05, has shown positive top-line results in patients with moderate to severe rheumatoid arthritis.

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA ... that are directed against TNF: infliximab, adalimumab, golimumab ...

Tumour Necrosis Factor TNF is crucial for defence but can drive chronic inflammation linked to arthritis and autoimmune diseases when overproduced ...

Experimental Findings Suggest the Involvement of TNF in the Disease Process Accumulated studies indicate the involvement of TNF in the disease process in animal arthritis models. TNF is generally ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

Deep pain at the back of the hip. Pain near the rear of your hip could be a sign of sciatica, a ligament injury, or one of ...

About AVT23 AVT23 is a monoclonal antibody and proposed biosimilar to Xolair ® (omalizumab). AVT23 is an investigational compound and has not received regulatory approval in any country. Biosimilarity ...

The European Medicines Agency (EMA) has accepted a marketing authorisation application (MAA) for Alvotech and Advanz Pharma’s ...

Ginger may contain beneficial components, including gingerols and shogaols. These compounds are thought to have antioxidant ...

A new study has found that those who ate right had both a lower chance of contracting COVID-19 and, on average, fared better if they caught the coronavirus. “Eating right” meant ...